Thompson Davis & Co’s Biohaven BHVN Stock Holding History

Thompson Davis & Co’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,000	Closed	-$273K	–	119
2024 Q1	$273K	Hold	5,000	–	–	0.19%	68
2023 Q4	$214K	Buy	+5,000	New	+$155K	0.18%	69

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Thompson Davis & Co's BHVN Position: Q2 2024 in Review

Thompson Davis & Co sold out of Biohaven (BHVN) in Q2 2024, closing a stake of 5,000 shares — an estimated $273K sold.

Thompson Davis & Co first reported a position in BHVN in Q4 2023 and held it in 2 quarters. The position peaked at $273K in Q1 2024. 225 funds tracked by Wall St. Rank hold BHVN as of Q2 2024.

Thompson Davis & Co reported no remaining Biohaven position as of Q2 2024 after selling out during the quarter.
Thompson Davis & Co sold 5,000 Biohaven shares in Q2 2024, an estimated $273K.
Thompson Davis & Co first reported a position in Biohaven in Q4 2023 and held it in 2 quarters.
Thompson Davis & Co's Biohaven position peaked at $273K in Q1 2024.
225 funds tracked by Wall St. Rank held Biohaven as of Q2 2024.

Based on Thompson Davis & Co's 13F filing for Q2 2024, filed 23 Jul 2024.